Invention Grant
- Patent Title: High affinity human antibodies to human nerve growth factor
- Patent Title (中): 人类神经生长因子高亲和力抗体
-
Application No.: US12188330Application Date: 2008-08-08
-
Publication No.: US07988967B2Publication Date: 2011-08-02
- Inventor: Lynn MacDonald , Richard Torres , Marc R Morra , Joel H Martin , Joel C Reinhardt
- Applicant: Lynn MacDonald , Richard Torres , Marc R Morra , Joel H Martin , Joel C Reinhardt
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agent Valeta Gregg, Esq.; Veronica Mallon
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/22

Abstract:
A human antibody or antigen-binding fragment of an antibody which specifically binds human nerve growth factor (NGF) with KD of 5 pM or less, as measured by surface plasmon resonance, wherein the antibody or fragment thereof binds human NGF with an affinity of about 2-10-fold higher than the antibody or fragment binds rat and mouse NGF. The antibodies are useful in treating pain, including inflammatory pain, post-operative incision pain, neuropathic pain, fracture pain, osteoporotic fracture pain, post-herpetic neuralgia, osteoarthritis, rheumatoid arthritis, cancer pain, pain resulting from burns, gout joint pain, as well as diseases, such as hepatocellular carcinoma, breast cancer, and liver cirrhosis.
Public/Granted literature
- US20090041717A1 HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN NERVE GROWTH FACTOR Public/Granted day:2009-02-12
Information query